Formulation of Piperine-Loaded Nanoemulsion: In Vitro Characterization, Ex Vivo Evaluation, and Cell Viability Assessment. 2023

Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Piperine is an alkaloid, but its therapeutic efficacy is limited due to poor aqueous solubility. In this study, piperine nanoemulsions were prepared using oleic acid (oil), Cremophore EL (surfactant), and Tween 80 (co-surfactant) using the high-energy ultrasonication approach. The optimal nanoemulsion (N2) was further evaluated using transmission electron microscopy, release, permeation, antibacterial, and cell viability studies based on minimal droplet size and maximum encapsulation efficiency. The prepared nanoemulsions (N1-N6) showed a transmittance of more than 95%, a mean droplet size between 105 ± 4.11 and 250 ± 7.4 nm, a polydispersity index of 0.19 to 0.36, and a ζ potential of -19 to -39 mV. The optimized nanoemulsion (N2) showed significantly improved drug release and permeation compared with pure piperine dispersion. The nanoemulsions were stable in the tested media. The transmission electron microscopy image showed a spherical and dispersed nanoemulsion droplet. The antibacterial and cell line results of piperine nanoemulsions were significantly better than the pure piperine dispersion. The findings suggested that piperine nanoemulsions may be a more advanced nanodrug delivery system than conventional ones.

UI MeSH Term Description Entries

Related Publications

Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
January 2022, ACS omega,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
October 2018, Pharmaceutical development and technology,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
July 2023, Gels (Basel, Switzerland),
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
May 2022, Molecules (Basel, Switzerland),
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
August 2021, AAPS PharmSciTech,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
October 2021, Nanomaterials (Basel, Switzerland),
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
March 2022, Polymers,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
September 2015, Advanced pharmaceutical bulletin,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
January 2020, Current drug delivery,
Sultan Alshehri, and Sarah I Bukhari, and Syed Sarim Imam, and Afzal Hussain, and Adel F Alghaith, and Mohammad A Altamimi, and Abdullah S AlAbdulkarim, and Alanood Almurshedi
March 2022, Pharmaceutical development and technology,
Copied contents to your clipboard!